Results 81 to 90 of about 6,549 (182)

Can non-tumorous liver tissue serve as a reliable reference measure for [18F]FDG-PET-CT after unilobar 90Y glass radioembolization in patients with colorectal liver metastases?

open access: yesEJNMMI Research
Background Effect of radiation on [18F]FDG-uptake in non-tumorous liver tissue after radioembolization is sparsely investigated, despite the liver being the most common reference for assessment of metabolic response (e.g., PET Response Criteria In Solid ...
Li Shen Ho   +5 more
doaj   +1 more source

Theranostics in Interventional Oncology: Versatile Carriers for Diagnosis and Targeted Image-Guided Minimally Invasive Procedures

open access: yesFrontiers in Pharmacology, 2019
We are continuously progressing in our understanding of cancer and other diseases and learned how they can be heterogeneous among patients. Therefore, there is an increasing need for accurate characterization of diseases at the molecular level.
Nils Degrauwe   +5 more
doaj   +1 more source

Holmium-166 Radioembolization of Hepatic Metastases in Salvage Setting: Preliminary Findings from a Single Center Experience

open access: yesJournal of Clinical Interventional Radiology ISVIR
Purpose The aim of this study is to report the early outcomes of holmium-166 (166Ho) radioembolization in the treatment of liver metastases.
Murat Dökdök, Kezban Berberoğlu
doaj   +1 more source

Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management

open access: yesCurrent Oncology
Neuroendocrine tumors (NETs) are a heterogeneous class of cancers, predominately occurring in the gastroenteropancreatic system, which pose a growing health concern with a significant rise in incidence over the past four decades.
Cody R. Criss, Mina S. Makary
doaj   +1 more source

Clinical course of patients with hepatocellular carcinoma who experienced radiologic complete response after radioembolization

open access: yesFrontiers in Oncology
PurposeThe purpose of this study is to elucidate the patterns of recurrence of hepatocellular carcinoma and to analyze factors that can predict recurrence after complete response to radioembolization.Materials and methodsA total of 289 consecutive ...
Sungmo Moon   +9 more
doaj   +1 more source

Current status of transarterial radioembolization

open access: yesWorld Journal of Radiology, 2016
Unresectable primary and secondary liver malignancies present a major problem in the treatment of solid tumors. Transarterial radioembolization (TARE) is an increasingly used technique for treating various types of malignant liver tumors. This approach is appealing, as the mechanism of action is independent from other loco-regional treatments and ...
openaire   +2 more sources

Radioembolization: Technical Tips and Follow-Up Imaging

open access: yesJournal of the Korean Society of Radiology
Transarterial radioembolization (TARE) is a minimally invasive treatment modality for hepatocellular carcinoma (HCC) that delivers targeted radiation via radioactive microspheres.
Hyo-Cheol Kim
doaj   +1 more source

The Essential Role of Monte Carlo Simulations for Lung Dosimetry in Liver Radioembolization—Part B: 166Ho Microspheres

open access: yesApplied Sciences
This study compares dosimetric approaches for lung dosimetry in 166 radioembolization (Ho-TARE) with direct Monte Carlo (MC) simulations on a voxelized anthropomorphic phantom derived from a real patient’s CT scan, preserving the patient’s lung density ...
Edoardo d’Andrea   +6 more
doaj   +1 more source

The State of the Art on Management of Patients with Unresectable Liver Metastases from Colorectal Cancer

open access: yesBiomedicines
Colorectal cancer frequently metastasizes to the liver, and a substantial proportion of patients present with unresectable colorectal liver metastases (CRLM), which are associated with limited survival.
Martim Porto   +8 more
doaj   +1 more source

Survival and Dosimetry in Advanced Hepatocellular Carcinoma with Tumor Sizes Up to 20 cm: A High Tumor Volume Institutional Cohort

open access: yesCerrahpaşa Medical Journal
Objective: Transarterial radioembolization with yttrium-90 (Y-90 TARE) is a well-established locoregional therapy for hepatocellular carcinoma (HCC) in patients who are not candidates for transarterial chemoembolization (TACE); however, its clinical ...
Seçkin Bilgiç   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy